Xu Zhang

A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma

Xu Zhang, Xiaojuan Gao, Tong Su, 2022, Cancer management and research.

CMAR_A_379911 3037..3046

Xu Zhang, Xiaojuan Gao, Tong Su, 2022 .